MAP1LC3C and cancer: Notably, the highest average expression of MAP1LC3C is observed in B-cells (0.0047 TPM, transcripts per million) and cancer cells (0.0036 TPM) with a large variation in expression between tumors (Fig 2B), suggesting that inter-cancer MAP1LC3C differences, as observed in TCGA data, are driven by expression differences in cancer cells.